GSK-205081

Study Sponsor: GSK

Study Title

Efficacy, immunogenicity and safety study of GSK Biologicals’ candidate malaria vaccine (SB257049) evaluating various dose schedules in a sporozoite challenge model in healthy malaria-naïve adults

Medicine or Vaccine (generic name)

RTS,S Vaccine

Sponsor Identification Number

205081

Trial Registry Identification Number(#'s)

NCT03162614

Medical Condition

Malaria

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205081

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03162614

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

September 2020